Author response: MicroRNA-26b protects against MASH development and can be efficiently targeted with lipid nanoparticles
Linsey J. F. Peters(Cardiovascular Institute Hospital), Emiel P. C. van der Vorst(RWTH Aachen University), Marcin Krawczyk(Universitätsklinikum des Saarlandes), Marion J. Gijbels(Maastricht University Medical Centre), Alexander Jans(Institute of Rheumatology), Peter Olinga(University of Groningen), Kiril Bidzhekov(Ludwig-Maximilians-Universität München), Cheng Lin(Institute of Rheumatology), Matthias Bartneck(DWI – Leibniz Institute for Interactive Materials), Andrea Bonnin-Marquez(RWTH Aachen University), Yvonne Döring(University of Bern), Sander S. Rensen(Maastricht University Medical Centre), Sanne L. Maas(German Centre for Cardiovascular Research), Yana Geng(Center for Digestive and Liver Diseases), Joachim Jankowski(Charité - Universitätsmedizin Berlin), Ronit Shiri‐Sverdlov(Maastricht University), Tom Houben(Maastricht University), Tim Hendrikx(Medical University of Vienna), Leonida Rakateli(RWTH Aachen University), Rosanna Huchzermeier(RWTH Aachen University), Malvina Brisbois(University Medical Center), Christian Weber(Munich Cluster for Systems Neurology), Alan Gorter(University of Groningen), Erik A.L. Biessen(Maastricht University Medical Centre)
Cited by 0
Related Papers
Microparticles
|Circulation Research|2010|769
Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis #
|Hepatology|2009|762
The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management
|Cells|2020|538
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
|Molecular & Cellular Proteomics|2010|537